Skip to main content
Log in

Abstract

Cytotoxic and antitumor activities of the biligand vanadyl derivative of L-malic acid, (bis-(L-malato)oxovanadium(IV) (VO(mal)2), the inorganic vanadium(IV) compound, vanadyl sulfate (VOSO4), the oxovanadium monocomplex with L-malic acid (VO(mal)), and the vanadyl biscomplex with acetylacetonate (VO(acac)2) were investigated using several tumor cell lines: mouse fibrosarcoma (L929), rat pheochromocytoma (PC12), human liver carcinoma (HepG2), mouse embryonic fibroblasts (NIH/3T3), and also normal human skin fibroblasts. The results showed that VO(mal)2 effectively inhibited growth of cancer cell cultures without any toxic effect on normal human skin fibroblasts. The cytotoxic anticancer effect of vanadium complexes depended on concentration of the compounds studied, incubation time, types of cell cultures, and nature of ligands surrounding the central group of the complex (VO2+). These studies provide evidence that VO(mal)2 may be considered as a potential anticancer agent due to its low toxicity for non-tumor cells and significant anticancer activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Amir, S., Meyerovich, J., and Shechter, Y., Brain Res., 1987, vol. 419, pp. 392–397.

    Article  CAS  Google Scholar 

  2. Brichard, S.M., Bailey, C.J., and Henquin, J.C., Diabetes, 1990, vol. 11, pp. 1126–1132.

    Google Scholar 

  3. Shechter, Y., Diabetes, 1990, vol. 39, pp. 1–5.

    Article  CAS  Google Scholar 

  4. Badmaev, V., Prakash, S., and Majeed, M., J. Alternat. Complement. Medicine, 1999, vol. 5, pp. 273–291.

    Article  CAS  Google Scholar 

  5. Orvig, C., Thompson, K.H., Battel, M., and McNeill, J.H., Met. Ions Biol. Syst., 1995, vol. 31, pp. 575–594.

    CAS  Google Scholar 

  6. Fu, Y., Wang, Q., Yang, X.G., Yang, X.D., and Wang, K., J. Biol. Inorg. Chem., 2008, vol. 13, pp. 1001–1009.

    Article  CAS  Google Scholar 

  7. Crans, D., J. Inorg. Biochem., 2000, vol. 80, pp. 123–131.

    Article  CAS  Google Scholar 

  8. Crans, D.C., Smee, J.J., Gaidamauskas, E., and Yang, L., Chem. Rev., 2004, vol. 104, pp. 849–942.

    Article  CAS  Google Scholar 

  9. Thompson, K.H. and Orvig, C., Dalton Trans., 2006, pp. 761–764.

  10. Bishayee, A., Oinam, S., Basu, M., and Chatterjiee, M., Breast Cancer Res. Treatment, 2000, vol. 63, pp. 133–145.

    Article  CAS  Google Scholar 

  11. Evangelou, A.M., Crit. Rev. Oncol./Hematol., 2002, vol. 42, pp. 249–265.

    Article  Google Scholar 

  12. Desoize, B., Anticancer Res., 2004, vol. 24, pp. 1529–1544.

    CAS  Google Scholar 

  13. Holko, P., Ligesa, J., Kisilewska, J., Kordowiak, A.M., and Klein, A., Pol. J. Patol., 2008, vol. 59, pp. 3–8.

    CAS  Google Scholar 

  14. Etcheverry, S.B., Ferrer, E.G., Naso, L., Rivadeneira, J., Salinas, V., and Williams, P.A., J. Biol. Inorg. Chem., 2008, vol. 13, pp. 435–447.

    Article  CAS  Google Scholar 

  15. Faneca, H., Figueiredo, V.A., Tomaz, I., Gonçalves, G., Avecilla, F., Pedroso de Lima, M.C., Geraldes, C.F., Pessoa, J.C., and Castro, M.M., J. Inorg. Biochem., 2009, vol. 103, pp. 601–608.

    Article  CAS  Google Scholar 

  16. Thompson, H.J., Chasteen, N.D., and Meeker, L.D., Carcinogenes, 1984, vol. 5, pp. 849–851.

    Article  CAS  Google Scholar 

  17. El-Naggar, M.M., El-Waseef, A.M., El-Halafawy, K.M., and El-Sayed, I.H., Cancer Lett., 1998, vol. 133, pp. 71–76.

    Article  CAS  Google Scholar 

  18. Osin-ska-Królicka, I., Podsiad’y, H., Bukietyńska, K., Zemanek-Zboch, M., Nowak, D., Suchoszekukaniuk, K., and Malicka-B’aszkiewicz, M., J. Inorg. Biochem., 2004, vol. 98, pp. 2087–2098.

    Article  Google Scholar 

  19. Liasko, R., Kabanos, T.A., Karkabounas, S., Malamas, M., Tasiopoulos, A.J., Stefanou, D., Collery, P., and Evangelou, A., Anticancer Res., 1998, vol. 18(5A), pp. 3609–3613.

    CAS  Google Scholar 

  20. Kopf-Maler, P., Eur. J. Clin. Pharmacol., 1994, vol. 47, pp. 1–16.

    Google Scholar 

  21. Belyaeva, N.F., Gorodetskii, V.K., Tochilkin, A.I., Golubev, M.A., Semenova, N.V., and Kovelman, I.R., Vopr. Med. Khim., 2000, vol. 46, pp. 344–360.

    CAS  Google Scholar 

  22. Gorodetskii, V.K., Tochilkin, A.I., Belyaeva, N.F., Kovelman, I.R., and Korovkin, B.F., Biomed. Khim., 2011, vol. 57, pp. 133–137.

    CAS  Google Scholar 

  23. Tochilkin, A.I., Belyaeva, N.F., Abakumova, O.Yu., and Podobed, O.V., Rus. Patent 2376020, 2009.

  24. Teixeira, M.H.S.F., Costa Pessoa, J., and Vilas Boas, L.F., Polyhedron, 1992, vol. 11, pp. 697–708.

    Article  CAS  Google Scholar 

  25. Abakumova, O.Yu, Podobed, O.V., Borisova, A.A., Sidoruk, K.V., Alexandrova, S.S., Omelyanuk, N.M., Pokrovskaya, M.V., Kondakova, L.I., and Sokolov, N.N., Biochemistry (Moscow) Supplement B: Biomedical Chemistry, 2009, vol. 3, pp. 198–201.

    Article  Google Scholar 

  26. Sakurai, H., Tsuchiya, K., Nukatsuka, M., et al., J. Endocrinol., 1990, vol. 126, pp. 451–459.

    Article  CAS  Google Scholar 

  27. Sakurai, H., Tamura, H., and Okatani, K., Biochim. Biophys. Res. Commun., 1995, vol. 206, pp.133–137.

    Article  CAS  Google Scholar 

  28. Stern, A., Yin, X., Tsang, S.S., Davison, A., and Moon, J., Biochem. Cell. Biol., 1993, vol. 71, pp. 103–112.

    Article  CAS  Google Scholar 

  29. Morinville, A., Maysinger, D., and Shaver, A., Trends Pharmacol. Sci., 1998, vol. 19, pp. 452–460.

    Article  CAS  Google Scholar 

  30. Wang, Q., Liu, T.-T., Fu, Y., Wang, K., and Yang, X.-G., J. Biol. Inorg. Chem., 2010, vol. 15, pp. 1087–1097.

    Article  CAS  Google Scholar 

  31. Ray, R.S., Basu, M., Ghosh, B., Samanta, K., and Chatterjee, M., Nutr. Cancer., 2005, vol. 51, pp. 184–196.

    Article  CAS  Google Scholar 

  32. Ray, R.S., Rana, B., Swami, B., Venu, V., and Chatterjee, M., Chem. Biol. Interact., 2006, vol. 163, pp. 239–247.

    Article  CAS  Google Scholar 

  33. Kostova, I., Anticancer Agents Med. Chem., 2009, vol. 9, pp. 827–842.

    CAS  Google Scholar 

  34. Bishayee, A., Waghray, A., Patel, M.A., and Chatterjee, M., Cancer Lett., 2010, vol. 294, pp. 1–12.

    Article  CAS  Google Scholar 

  35. Cruz, O.J.D. and Uckun, F.M., Expert Opin. Investig. Drugs, 2002, vol. 11, pp. 1829–1836.

    Article  Google Scholar 

  36. Narla, R.K., Dong, Y., D’Cruz, O.J., Navara, C., and Uckun, F.M., Clin. Cancer. Res., 2000, vol. 6, pp. 1546–1556.

    CAS  Google Scholar 

  37. Chakraborty, T., Samanta, S., Ghosh, B., Thirumoorthy, N., Chatterjee, M., J. Cell. Biochem., 2005, vol. 94, pp. 744–762.

    Article  CAS  Google Scholar 

  38. Chen, D., Milacic, V., Frezza, M., and Dou, Q.P., Curr. Pharm. Des., 2009, vol. 15, pp. 777–791.

    Article  CAS  Google Scholar 

  39. Yuen, V.G., Orvig, C., Tompson, K.H., and McNeill, J.H., Can. J. Physiol. Pharmacol., 1993, vol. 71, pp. 270–276.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. F. Belayeva.

Additional information

Original Russian Text © O.Yu. Abakumova, O.V. Podobed, N.F. Belayeva, A.I. Tochilkin, 2012, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abakumova, O.Y., Podobed, O.V., Belayeva, N.F. et al. Anticancer activity of oxovanadium compounds. Biochem. Moscow Suppl. Ser. B 6, 164–170 (2012). https://doi.org/10.1134/S1990750812020023

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750812020023

Keywords

Navigation